$MRNA Moderna, Inc. Insider Trading Week 13/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Moderna, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Moderna, Inc. in week 13/2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 02 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 132.51 | 10,000 | 1,325,100 | 7,474,880 | 7.5 M to 7.5 M (-0.13 %) |
| Apr 02 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Gift | G | 0.00 | 2,000 | 0 | 6,378,868 | 6.4 M to 6.4 M (-0.03 %) |
| Apr 02 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 121.10 | 9,000 | 1,089,900 | 6,380,868 | 6.4 M to 6.4 M (-0.14 %) |
| Apr 02 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 159,476 | |
| Apr 02 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 132.51 | 6,600 | 874,566 | 901 | 7.5 K to 901 (-87.99 %) |
| Apr 02 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
| Apr 01 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Option Exercise | M | 20.93 | 6,600 | 138,138 | 166,076 | |
| Apr 01 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Sell | S | 123.30 | 6,600 | 813,780 | 901 | 7.5 K to 901 (-87.99 %) |
| Apr 01 2021 | MRNA | Moderna, Inc. | HENDERSON LORI M. | General Counsel and ... | Buy | M | 20.93 | 6,600 | 138,138 | 7,501 | 901 to 7.5 K (+732.52 %) |
| Apr 01 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 594,822 | |
| Apr 01 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 121.10 | 5,000 | 605,500 | 0 | 5 K to 0 (-100.00 %) |
| Apr 01 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 121.07 | 4,888 | 591,810 | 9,116,657 | 9.1 M to 9.1 M (-0.05 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.44 | 1,000 | 123,440 | 9,121,545 | 9.1 M to 9.1 M (-0.01 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.08 | 31,943 | 3,931,538 | 9,122,545 | 9.2 M to 9.1 M (-0.35 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 121.71 | 14,379 | 1,750,038 | 9,154,488 | 9.2 M to 9.2 M (-0.16 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 120.76 | 225,732 | 27,259,283 | 9,168,867 | 9.4 M to 9.2 M (-2.40 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 119.81 | 344,542 | 41,278,061 | 9,394,599 | 9.7 M to 9.4 M (-3.54 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 118.90 | 611,922 | 72,758,505 | 9,739,141 | 10.4 M to 9.7 M (-5.91 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 118.04 | 883,277 | 104,265,815 | 10,351,063 | 11.2 M to 10.4 M (-7.86 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 131.30 | 558 | 73,265 | 11,234,340 | 11.2 M to 11.2 M (0.00 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 130.56 | 6,610 | 862,994 | 11,234,898 | 11.2 M to 11.2 M (-0.06 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 129.54 | 83,242 | 10,783,377 | 11,241,508 | 11.3 M to 11.2 M (-0.74 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 128.74 | 123,374 | 15,883,527 | 11,324,750 | 11.4 M to 11.3 M (-1.08 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 127.47 | 46,872 | 5,974,788 | 11,448,124 | 11.5 M to 11.4 M (-0.41 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 126.40 | 82,557 | 10,434,924 | 11,494,996 | 11.6 M to 11.5 M (-0.71 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 125.36 | 116,383 | 14,589,226 | 11,577,553 | 11.7 M to 11.6 M (-1.00 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 124.42 | 251,545 | 31,296,927 | 11,693,936 | 11.9 M to 11.7 M (-2.11 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 123.50 | 639,681 | 78,998,365 | 11,945,481 | 12.6 M to 11.9 M (-5.08 %) |
| Mar 31 2021 | MRNA | Moderna, Inc. | AFEYAN NOUBAR | Director | Sell | S | 122.54 | 284,300 | 34,836,672 | 12,585,162 | 12.9 M to 12.6 M (-2.21 %) |
| Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 134.72 | 500 | 67,360 | 99,430 | 99.9 K to 99.4 K (-0.50 %) |
| Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 134.10 | 3,200 | 429,120 | 99,930 | 103.1 K to 99.9 K (-3.10 %) |
| Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 133.06 | 3,006 | 399,978 | 103,130 | 106.1 K to 103.1 K (-2.83 %) |
| Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 132.04 | 2,915 | 384,897 | 106,136 | 109.1 K to 106.1 K (-2.67 %) |
| Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 130.73 | 700 | 91,511 | 109,051 | 109.8 K to 109.1 K (-0.64 %) |
| Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 129.40 | 300 | 38,820 | 109,751 | 110.1 K to 109.8 K (-0.27 %) |
| Mar 30 2021 | MRNA | Moderna, Inc. | Bancel Stephane | Chief Executive Off ... | Sell | S | 128.89 | 425 | 54,778 | 110,051 | 110.5 K to 110.1 K (-0.38 %) |
| Mar 30 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Option Exercise | M | 12.21 | 5,000 | 61,050 | 599,822 | |
| Mar 30 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Sell | S | 130.05 | 5,000 | 650,250 | 0 | 5 K to 0 (-100.00 %) |
| Mar 30 2021 | MRNA | Moderna, Inc. | Andres Juan | See remarks | Buy | M | 12.21 | 5,000 | 61,050 | 5,000 | 0 to 5 K |